In myeloid malignancies, JMJD3 impaired osteoclast formation through increasing the level of H3K27me3 on the nuclear factor for activated T cells 1 (NFATc1) promoter to promote myeloid malignancies (Rohatgi et al. 2018). Here, NFATC1 is linked to myeloid neoplasm.